UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000012063
Receipt No. R000014103
Scientific Title Multicenter Phase II study of combination therapy with S-1 plus Irinotecan plus Cetuximab (MetronomicIRIS/Cmab combination therapy) in patients with KRAS wild type unresectable colorectal cancer, who had previously received on fluoropyrimidine , oxaliplatin , irinotecan and bevacizumab. (KSCOG CR-06)
Date of disclosure of the study information 2013/10/18
Last modified on 2016/10/28 13:52:43

No. Disposal Last modified on Item of update
1 Insert 2013/10/17 19:53:53
2 Update 2016/10/28 13:52:44 Recruitment status
Last follow-up date
Date of closure to data entry

Contact us.